Secukinumab 2023 medical insurance price

Secukinumab belongs to a class of drugs called monoclonal antibodies, which work by stopping the activity of certain cells in the body that cause the symptoms of psoriasis. Secukinumab is used to treat moderate to severe plaque psoriasis (a skin disease that forms red, scaly plaques on certain parts of the body) in adults whose psoriasis is so severe that it cannot be treated with topical medications alone. It is also used in adults to treat psoriatic arthritis (a disease that causes pain and swelling in the joints and scaly skin).

Secukinumab is used in adults to treat ankylosing spondylitis (a disease in which the body attacks the joints in the spine and other areas, causing pain, swelling, and joint damage), in adults to treat nonradiographic active axial spondyloarthritis (a disease in which the body attacks the joints and other areas of the spine, causing signs of pain and swelling, but no change visible on an x-ray), and to treat enthesitis-related arthritis in children 4 years and older.

Secukinumab The original drug has been launched in China and has entered the scope of Class B medical insurance. However, domestic patients who can purchase this drug are limited to eligible patients with psoriasis and ankylosing spondylitis. Patients who are not eligible for medical insurance reimbursement can only purchase it at their own expense. The price of each box of 150mg/ML is about RMB 1,000. SecukinumabThe original drug has also been launched overseas. The specifications of the Turkish original versionThe price per box of 150mg/ML is about 1,500 yuan, and the European version is 150m. The price of each box of g/ML*2 is around RMB 15,000 (the price may fluctuate due to the exchange rate). The ingredients of foreign original drugs and domestic original drugs are basically the same. Currently, there are no generic secukinumab drugs on the market.